Treatment-emergent adverse events (TEAE) in children with Ataxia-Telangiectasia treated for one year with intra-erythrocyte dexamethasone sodium phosphate (EryDex

Authors
Category Primary study
Conference53rd Child Neurology Society Annual Meeting
Year 2024
This article has no abstract
Epistemonikos ID: 52a9677943f8321e995966eee56c869869039d48
First added on: Feb 16, 2026